Parametric Equity Plus ETF (PEPS)

Holding for the big money. Had a nice week on my Rolls Royces selling 100 share blocks - next one is set to go at $21 I really think $25 - $30 is where it will wind up. Then I sold 5000 shares of SHAZW(all they gave me) total cost $9.45 including commish and sold for $1598.xx

Doubt

Again, OTC has made R/S infamous as it usually means the stock death certificate.
With a growing flourishing company R/S at a certain share price to get the OS structure in check = I am all for it. Bullish as F**K

Neugebauer Suspends Current Proxy Campaign While Leading with About 70% of Votes Recorded, Following Judge's Inexplicable Last-minute Recusal That Throws off Timeline for Strategic Process; Reaffirms Confidence in Fermi's FutureJuly 3, 2026 1:33 PM
PR Newswire (US)

Thank you for this very informative answer.
Based on the volume of trading on June 26, 30 and July 1st, you may assume that of these ATM trading took place.

That is why my response is hence, needs to grow organically.

Fantastic. congrats

Kiwi

Any sign of NWBO amplifying the results?

I would be absolutely stunned if NWBO issued a PR discussing the results. Our best hope is likely a news outlet picking it up and publishing something.

That being said, if NWBO put out a PR with an attention grabbing headline som

Rapz, would you mind explaining what you mean by your statement:
"Wishful thinking indeed and at this stage of the VP game not reasonable at all. Any idea of settlement by year end is out the window. See you all next June!"
Thanks!

https://investorshub.advfn.com/uimage/uploads/2026/7/3/coksxGUTSI_WE_FEEL_GOOD_3.jpg

I should be in advertising
.

Not yet currently 660% showing but then again it's all profit since I sold enough for 200% wayyyyyy long ago. My cost basis is $2.406

I will likely buy more this week after a long time

So many investors may be missing the boat on IOVA. Despite its early missteps, it may be time to look again at taking a postion in IOVA:

https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-iova/iovance-biotherapeutics/ismg0jwg-why-i-think-iovance-is-undervalu

Any update from PAC on the DE docket or at DTC?.
Gemini's Response:
As of today, **July 1, 2026**, there are still **no new active changes, public distribution notifications, or sudden judicial updates** on the Delaware Court of Chancery docket or from the Depository Trust Company (DTC

I always find it interesting when folks ask "how do I find" a contact, person, CEO, Marketing, email, phone number , history , DD , filings or trying to verify what
is said here instead of just doing the following.
a. Google the person
b. Google the filing
c. Look a

Are U up about 10X on this ??

Kiwi

Karen Firestone from CNBC ..ex Fidelity biotech fund manager I think
Karen Firestone (Amylyx Board Member): She is the co-founder, CEO, and Chairman of Aureus Asset Management.
She sits on the Amylyx Board as a member of both the Audit and the Nominating and Corporate Governance comm

Interesting, too, that using the MAIC actually underestimated the results, erring on the side of extreme caution in presenting the results.

I'm guessing no one, including the company, the regulators, and even (especially?) the shorts thought that applying Individual Patient Data (IPD)

Sounds like a winner to me.

$TWOH Just like OTC message boards are notorious for mentioning RS just for the heck of it

New Substack article today! Gearing up for something me thinks.

the ZRI-X's are super cool, BAD SUNNY........twice the price and for some reason............hated by vette people.......??.......and the sales and depreciation are wicked........????..........no worries, BAD SUNNY...................

produce on those UWBI cusips and I will be dropping

I think this company is dead. Very little hope left after owning it for 19 years

I will be buying more at this cheap price starting Monday morning.Our time for cheap shares is running out.

Don’t jinx it.

Every time someone says that, you turn around a year later and it’s still cheap.

That said, LC might be just have to be disappoint

Anyone else notice the bashers are promoting the glue company?
Should explain why they are here.
They'll deny it, but it's pretty obvious.
Ignore them.
Don't give them a platform.
IDE decision Monday?

Simply put, this data not only puts to rest but absolutely crushes every single bear criticism of the original trial result readout and analysis.

Even Nemisis has immediately changed his tune from “DCVax was DOA as soon as the application was submitted” to “well we still have to wait